Publicacions en què col·labora amb José Ignacio López Villalba (34)

2025

  1. Lipid imaging mass spectrometry: Towards a new molecular histology

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1870, Núm. 1

2024

  1. Clear Cell Renal Cell Carcinoma: A Test Bench for Investigating Tumor Complexity

    Cancers

  2. Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

  3. Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy

    Cancers, Vol. 16, Núm. 16

  4. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Author Correction: The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma (Scientific Reports, (2023), 13, 1, (7339), 10.1038/s41598-023-34087-x)

    Scientific Reports

  2. Fibroblast Activation Protein-α (FAP) Identifies Stromal Invasion in Colorectal Neoplasia

    The American journal of surgical pathology, Vol. 47, Núm. 9, pp. 1027-1033

  3. The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma

    Scientific Reports, Vol. 13, Núm. 1

2021

  1. (Pro)renin receptor is a novel independent prognostic marker in invasive urothelial carcinoma of the bladder

    Cancers, Vol. 13, Núm. 22

  2. Clinical implications of (Pro)renin receptor (prr) expression in renal tumours

    Diagnostics, Vol. 11, Núm. 2

  3. Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 4, pp. 1-17

2020

  1. Altered tissue and plasma levels of fibroblast activation protein-α (FAP) in renal tumours

    Cancers, Vol. 12, Núm. 11, pp. 1-16

  2. The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions

    Journal of Advanced Research, Vol. 21, pp. 103-108

2019

  1. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder

    Human Pathology, Vol. 91, pp. 61-68

2018

  1. High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma

    Annals of Diagnostic Pathology, Vol. 34, pp. 27-30

2017

  1. Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients

    PLoS ONE, Vol. 12, Núm. 8

2016

  1. Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma

    Human Pathology, Vol. 54, pp. 100-105

  2. Low-grade metastases in high-grade clear cell renal cell carcinomas A clinicopathologic study of 4 cases with an insight into the role of mesenchymal-to-epithelial transition process

    Annals of Diagnostic Pathology, Vol. 20, pp. 13-18

  3. The expression of fibroblast activation protein in clear cell renal cell carcinomas is associated with synchronous lymph node metastases

    PLoS ONE, Vol. 11, Núm. 12

2015

  1. Altered activity and expression of cytosolic peptidases in colorectal cancer

    International Journal of Medical Sciences, Vol. 12, Núm. 6, pp. 458-467